Niazi explains that tirzepatide is a newer dual-agonist that targets both the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor, which he says offers superior metabolic regulation and appetite suppression. Mounjaro is currently FDA-approved for type 2 diabetes, and Zepbound is also FDA-approved for weight loss
Based on direct head-to-head clinical trials, tirzepatide consistently achieves superior metabolic efficacy, specifically regarding weight loss and HbA1c reduction
152 High sensitivity (hs)-CRP is a test that detects the very small rises in CRP associated with vascular inflammation and atherosclerosis
Based on logistic regression analyses, it was found that obesity was associated with an almost 10-fold increase risk of Alzheimer's disease
At 5 mg/mL, that same two-unit error changes your dose by only 0.1 mg
Some users find chicken dry and difficult to eat when nauseous, so moisture matters